1. Home
  2. IOVA vs LFST Comparison

IOVA vs LFST Comparison

Compare IOVA & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • LFST
  • Stock Information
  • Founded
  • IOVA 2007
  • LFST 2015
  • Country
  • IOVA United States
  • LFST United States
  • Employees
  • IOVA N/A
  • LFST N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • LFST Medical/Nursing Services
  • Sector
  • IOVA Health Care
  • LFST Health Care
  • Exchange
  • IOVA Nasdaq
  • LFST Nasdaq
  • Market Cap
  • IOVA 3.0B
  • LFST 2.8B
  • IPO Year
  • IOVA N/A
  • LFST 2021
  • Fundamental
  • Price
  • IOVA $8.18
  • LFST $7.14
  • Analyst Decision
  • IOVA Strong Buy
  • LFST Hold
  • Analyst Count
  • IOVA 9
  • LFST 6
  • Target Price
  • IOVA $23.33
  • LFST $8.42
  • AVG Volume (30 Days)
  • IOVA 7.2M
  • LFST 1.6M
  • Earning Date
  • IOVA 11-07-2024
  • LFST 11-07-2024
  • Dividend Yield
  • IOVA N/A
  • LFST N/A
  • EPS Growth
  • IOVA N/A
  • LFST N/A
  • EPS
  • IOVA N/A
  • LFST N/A
  • Revenue
  • IOVA $90,858,000.00
  • LFST $1,206,093,000.00
  • Revenue This Year
  • IOVA $13,827.67
  • LFST $18.50
  • Revenue Next Year
  • IOVA $183.70
  • LFST $13.19
  • P/E Ratio
  • IOVA N/A
  • LFST N/A
  • Revenue Growth
  • IOVA 12751.20
  • LFST 20.08
  • 52 Week Low
  • IOVA $4.44
  • LFST $4.64
  • 52 Week High
  • IOVA $18.33
  • LFST $9.20
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 32.59
  • LFST 52.05
  • Support Level
  • IOVA $9.31
  • LFST $7.13
  • Resistance Level
  • IOVA $10.86
  • LFST $7.53
  • Average True Range (ATR)
  • IOVA 0.71
  • LFST 0.31
  • MACD
  • IOVA -0.37
  • LFST 0.01
  • Stochastic Oscillator
  • IOVA 1.48
  • LFST 26.13

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About LFST LifeStance Health Group Inc.

LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering.

Share on Social Networks: